Néstor J. Martínez Hernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Néstor J. Martínez Hernández has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Amparo Roig-Bataller
Department of Thoracic Surgery, University Hospital of la Ribera , València
5 shared publications- David Hervás
Department of Applied Statistics and Operational Research and Quality, Universitat Politècnica de València, València, Spain
4 shared publications Míriam Estors-Guerrero
Department of Thoracic Surgery, University Hospital of la Ribera , València
3 shared publications- Alberto Cabañero-Sánchez
Servicio de Cirugía Torácica, Hospital Universitario Ramón y Cajal, Madrid, Spain
2 shared publications José M. Galbis-Caravajal
Thoracic Surgery Department, Hospital Universitari de la Ribera, Alzira, València, Spain
2 shared publications- Manuel Mata
Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010 Valencia, Spain
2 shared publications
Latest Publications
- 5 February 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (2)
Standardized Recommendations for the Implementation of Enhanced Recovery Protocols in Thoracic Surgery in Spain: A Delphi Consensus Study
Objectives: Despite advancements in minimally invasive techniques, lung resection surgery for lung cancer still carries a significant risk of complications. Enhanced recovery after surgery (ERAS) protocols offer strategies to improve outcomes, yet their adoption is still inconsistent. This study aims to develop a series of evidence-based recommendations for ERAS strategies, incorporating insights from thoracic surgeons, anaesthetists, nurses, physiotherapists, and patients. Methods: A 2-round Delphi consensus process was conducted with experts in the management of thoracic surgery patients. A scientific committee established 62 recommendations across 3 phases: preoperative (n = 12), intraoperative (n = 30), and postoperative (n = 20). Consensus was defined as ≥66% agreement (Likert scale 6-7) or disagreement (Likert 1-2) among panellists. Results: Consensus was reached for 91.7% of preoperative, 86.7% of intraoperative, and 85% of postoperative recommendations. Key recommendations include structured prehabilitation programmes, multimodal analgesia strategies with opioid-sparing approaches, minimally invasive thoracic surgery, early chest drain removal, and pre- and postoperative physiotherapy with early mobilization. Conclusions: This study establishes a structured, consensus-based perioperative management protocol for thoracic surgery patients. By optimizing perioperative care and standardizing interventions, these recommendations aim to improve clinical outcomes, enhance recovery, and raise the quality of care during thoracic surgery. They may also facilitate the broader adoption of ERAS strategies, ultimately improving patient recovery and resource utilization.
- 5 February 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (2)
Standardized Recommendations for the Implementation of Enhanced Recovery Protocols in Thoracic Surgery in Spain: A Delphi Consensus Study
Objectives: Despite advancements in minimally invasive techniques, lung resection surgery for lung cancer still carries a significant risk of complications. Enhanced recovery after surgery (ERAS) protocols offer strategies to improve outcomes, yet their adoption is still inconsistent. This study aims to develop a series of evidence-based recommendations for ERAS strategies, incorporating insights from thoracic surgeons, anaesthetists, nurses, physiotherapists, and patients. Methods: A 2-round Delphi consensus process was conducted with experts in the management of thoracic surgery patients. A scientific committee established 62 recommendations across 3 phases: preoperative (n = 12), intraoperative (n = 30), and postoperative (n = 20). Consensus was defined as ≥66% agreement (Likert scale 6-7) or disagreement (Likert 1-2) among panellists. Results: Consensus was reached for 91.7% of preoperative, 86.7% of intraoperative, and 85% of postoperative recommendations. Key recommendations include structured prehabilitation programmes, multimodal analgesia strategies with opioid-sparing approaches, minimally invasive thoracic surgery, early chest drain removal, and pre- and postoperative physiotherapy with early mobilization. Conclusions: This study establishes a structured, consensus-based perioperative management protocol for thoracic surgery patients. By optimizing perioperative care and standardizing interventions, these recommendations aim to improve clinical outcomes, enhance recovery, and raise the quality of care during thoracic surgery. They may also facilitate the broader adoption of ERAS strategies, ultimately improving patient recovery and resource utilization.
- Open Access
- 30 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2401
Experimental Airway Allogenic Transplantation Model with Decellularized Cryopreserved Tracheas
Background/Objectives: Tracheal replacement remains an unmet necessity in airway pathology treatment. We describe a decellularization and cryopreservation tracheal replacement protocol tested in vivo. Methods: A prospective experimental cohort study is conducted in which tracheas from white New Zealand rabbits (n = 32) are decellularized and cryopreserved, sterilized with gamma radiation, and tutorized with a stent. Bilateral, pedicled fasciomuscular flaps are harvested, implanting one cryopreserved and one non-cryopreserved in each of 16 rabbits, dividing them into four groups (remaining tracheas implanted at 2, 4, 8, and 12 weeks, respectively). After removal, the tracheas are both histologically and biomechanically evaluated. Results: Decellularization is effective, with minimal effects on the biomechanical characteristics of the trachea. Implantation results in a well-vascularized organ, with no inflammatory or tissular rejection cellular response. Organs achieve all basal histological and biomechanical characteristics within 8 weeks of implantation, with no differences observed between cryopreserved and non-cryopreserved scaffolds. Conclusions: The present decellularization and cryopreservation protocol yields biocompatible, well-tolerated by the host tracheas with analogous histological and biomechanical characteristics to native ones.
- 30 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2401
Open AccessExperimental Airway Allogenic Transplantation Model with Decellularized Cryopreserved Tracheas
Background/Objectives: Tracheal replacement remains an unmet necessity in airway pathology treatment. We describe a decellularization and cryopreservation tracheal replacement protocol tested in vivo. Methods: A prospective experimental cohort study is conducted in which tracheas from white New Zealand rabbits (n = 32) are decellularized and cryopreserved, sterilized with gamma radiation, and tutorized with a stent. Bilateral, pedicled fasciomuscular flaps are harvested, implanting one cryopreserved and one non-cryopreserved in each of 16 rabbits, dividing them into four groups (remaining tracheas implanted at 2, 4, 8, and 12 weeks, respectively). After removal, the tracheas are both histologically and biomechanically evaluated. Results: Decellularization is effective, with minimal effects on the biomechanical characteristics of the trachea. Implantation results in a well-vascularized organ, with no inflammatory or tissular rejection cellular response. Organs achieve all basal histological and biomechanical characteristics within 8 weeks of implantation, with no differences observed between cryopreserved and non-cryopreserved scaffolds. Conclusions: The present decellularization and cryopreservation protocol yields biocompatible, well-tolerated by the host tracheas with analogous histological and biomechanical characteristics to native ones.
- 24 March 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (4)
Long-term outcomes and predictors of compensatory sweating after bilateral endoscopic thoracic sympathectomy
OBJECTIVES: Bilateral endoscopic thoracic sympathectomy is an effective treatment for primary hyperhidrosis, yet the causes of its main side effect, compensatory sweating, remain unclear. This study aimed to identify risk factors for compensatory sweating in a long-term follow-up cohort. METHODS: Patients who underwent bilateral endoscopic thoracic sympathectomy for primary hyperhidrosis between 2010 and 2023 (n = 98) were interviewed, and preoperative data were collected. Compensatory sweating was classified as mild, moderate, or severe according to the Society of Thoracic Surgeons guidelines. Quality of life (QOL) was assessed using the Hyperhidrosis Disease Severity Scale from the International Hyperhidrosis Society. Logistic and ordinal Bayesian regression models were applied to analyse associations between predictors, compensatory sweating outcomes, and QOL. RESULTS: The procedure achieved an overall effectiveness of 94.38%, with 34.69% of patients reporting compensatory sweating, predominantly mild (26.53%). Nearly all patients (97.95%) experienced a ≥ 50% reduction in sweating, and 94.89% achieved ≥80% reduction. Higher haemoglobin levels and marijuana protected against compensatory sweating incidence and severity. Conversely, smoking and hyperhidrosis involving both hands and axillae increased compensatory sweating risk. Better QOL outcomes were correlated with higher haemoglobin levels and female sex, while worse outcomes were associated with older age, higher body mass index, and axillary involvement. CONCLUSIONS: Long-term follow-up highlights key predictors for compensatory sweating, emphasizing the importance of tailored preoperative counseling. Identifying at-risk patients, such as smokers and those with low haemoglobin levels, is essential for improving outcomes and managing expectations in the treatment of primary hyperhidrosis.
- 24 March 2025
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 67 (4)
Long-term outcomes and predictors of compensatory sweating after bilateral endoscopic thoracic sympathectomy
OBJECTIVES: Bilateral endoscopic thoracic sympathectomy is an effective treatment for primary hyperhidrosis, yet the causes of its main side effect, compensatory sweating, remain unclear. This study aimed to identify risk factors for compensatory sweating in a long-term follow-up cohort. METHODS: Patients who underwent bilateral endoscopic thoracic sympathectomy for primary hyperhidrosis between 2010 and 2023 (n = 98) were interviewed, and preoperative data were collected. Compensatory sweating was classified as mild, moderate, or severe according to the Society of Thoracic Surgeons guidelines. Quality of life (QOL) was assessed using the Hyperhidrosis Disease Severity Scale from the International Hyperhidrosis Society. Logistic and ordinal Bayesian regression models were applied to analyse associations between predictors, compensatory sweating outcomes, and QOL. RESULTS: The procedure achieved an overall effectiveness of 94.38%, with 34.69% of patients reporting compensatory sweating, predominantly mild (26.53%). Nearly all patients (97.95%) experienced a ≥ 50% reduction in sweating, and 94.89% achieved ≥80% reduction. Higher haemoglobin levels and marijuana protected against compensatory sweating incidence and severity. Conversely, smoking and hyperhidrosis involving both hands and axillae increased compensatory sweating risk. Better QOL outcomes were correlated with higher haemoglobin levels and female sex, while worse outcomes were associated with older age, higher body mass index, and axillary involvement. CONCLUSIONS: Long-term follow-up highlights key predictors for compensatory sweating, emphasizing the importance of tailored preoperative counseling. Identifying at-risk patients, such as smokers and those with low haemoglobin levels, is essential for improving outcomes and managing expectations in the treatment of primary hyperhidrosis.
- 27 January 2025
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 103 (5) , 302-307
Advances and stagnation in airway surgery: A historical perspective
- 27 January 2025
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 103 (5) , 302-307
Advances and stagnation in airway surgery: A historical perspective
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (12) , 8292-8299
Endoscopic thoracic sympathectomy for primary hyperhidrosis: an over a decade-long follow-up on efficacy, impact, and patient satisfaction
Background: Endoscopic thoracic sympathectomy is a well-known and effective treatment for palmar and axillary primary hyperhidrosis (PHH). Its most frequent drawback and the main complaint among patients who underwent surgery is the appearance of compensatory sweating (CS). To date, no long-term studies using internationally standardized tools have assessed the efficacy and impact of this surgery on patients. In this study we performed a very long-term follow-up of the patients using an internationally validated tool. The aim of this article is to assess the technique as a treatment for hyperhidrosis, focusing on its long-term efficacy, side effects (CS), and patient satisfaction with the procedure. Methods: A closed cohort study was performed conducting a review of the clinical records to identify 100 consecutive patients who underwent bilateral endoscopic thoracic surgery with a minimum follow-up period of 2 years. Patients with diagnoses other than primary palmar or axillary hyperhidrosis or those for whom follow-up was impossible were excluded. A structured telephone survey, including the International Hyperhidrosis Society “Hyperhidrosis Disease Severity Scale” (HDSS) was conducted for all patients. Data were summarized using median (1st and 3rd quartiles) for quantitative variables and relative and absolute frequencies for qualitative variables. To study the likelihood of a patient recommending the surgery, a Bayesian logistic regression model was used reporting results as odds ratio (OR). Results: A total of 91 patients were included in the follow-up. The median follow-up duration was 10.66 (5.68, 11.98) years. The most affected zone was the hands (29.67%), and the most common sympathectomy levels were R2 and R3 (68.13%). The overall surgical efficacy rate was of 94.50% and CS appeared in 36.26% of the patients, with 75.76% of these cases being mild and severe in only one patient. In total, 97.8% of patients improved their HDSS score after surgery. The OR of recommending the surgery for a lower HDSS index was 0.24 and 0.18 for the apparition of CS. Despite it, 91.21% of patients recommend the surgery, with an overall satisfaction rate of 93.95%. Conclusions: Endoscopic thoracic sympathectomy is an effective and safe treatment for palmar and axillary PHH, with a relatively low rate of CS which, when present, is typically mild, making it a highly satisfactory treatment option for patients.
- 1 December 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (12) , 8292-8299
Open AccessEndoscopic thoracic sympathectomy for primary hyperhidrosis: an over a decade-long follow-up on efficacy, impact, and patient satisfaction
Background: Endoscopic thoracic sympathectomy is a well-known and effective treatment for palmar and axillary primary hyperhidrosis (PHH). Its most frequent drawback and the main complaint among patients who underwent surgery is the appearance of compensatory sweating (CS). To date, no long-term studies using internationally standardized tools have assessed the efficacy and impact of this surgery on patients. In this study we performed a very long-term follow-up of the patients using an internationally validated tool. The aim of this article is to assess the technique as a treatment for hyperhidrosis, focusing on its long-term efficacy, side effects (CS), and patient satisfaction with the procedure. Methods: A closed cohort study was performed conducting a review of the clinical records to identify 100 consecutive patients who underwent bilateral endoscopic thoracic surgery with a minimum follow-up period of 2 years. Patients with diagnoses other than primary palmar or axillary hyperhidrosis or those for whom follow-up was impossible were excluded. A structured telephone survey, including the International Hyperhidrosis Society “Hyperhidrosis Disease Severity Scale” (HDSS) was conducted for all patients. Data were summarized using median (1st and 3rd quartiles) for quantitative variables and relative and absolute frequencies for qualitative variables. To study the likelihood of a patient recommending the surgery, a Bayesian logistic regression model was used reporting results as odds ratio (OR). Results: A total of 91 patients were included in the follow-up. The median follow-up duration was 10.66 (5.68, 11.98) years. The most affected zone was the hands (29.67%), and the most common sympathectomy levels were R2 and R3 (68.13%). The overall surgical efficacy rate was of 94.50% and CS appeared in 36.26% of the patients, with 75.76% of these cases being mild and severe in only one patient. In total, 97.8% of patients improved their HDSS score after surgery. The OR of recommending the surgery for a lower HDSS index was 0.24 and 0.18 for the apparition of CS. Despite it, 91.21% of patients recommend the surgery, with an overall satisfaction rate of 93.95%. Conclusions: Endoscopic thoracic sympathectomy is an effective and safe treatment for palmar and axillary PHH, with a relatively low rate of CS which, when present, is typically mild, making it a highly satisfactory treatment option for patients.
- 3 June 2023
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 101 (12) , 853-861
Impact of COVID-19 pandemic in thoracic surgery training in Spain
- 3 June 2023
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 101 (12) , 853-861
Impact of COVID-19 pandemic in thoracic surgery training in Spain
- 14 April 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 194,p. e64432
Low-Dose Gamma Radiation Sterilization for Decellularized Tracheal Grafts
One of the main key aspects in ensuring that a transplant evolves correctly is the sterility of the medium. Decellularized tracheal transplantation involves implanting an organ that was originally in contact with the environment, thus not being sterile from the outset. While the decellularization protocol (through detergent exposition [2% sodium dodecyl sulfate], continuous stirring, and osmotic shocks) is conducted in line with aseptic measures, it does not provide sterilization. Therefore, one of the main challenges is ensuring sterility prior to in vivo implantation. Although there are established gamma radiation sterilization protocols for inorganic materials, there are no such measures for organic materials. Additionally, the protocols in place for inorganic materials cannot be applied to organic materials, as the established radiation dose (25 kGy) would completely destroy the implant. This paper studies the effect of an escalated radiation dose in a decellularized rabbit trachea. We maintained the dose range (kGy) and tested escalated doses until finding the minimal dose at which sterilization is achieved. After determining the dose, we studied effects of it on the organ, both histologically and biomechanically. We determined that while 0.5 kGy did not achieve sterility, doses of both 1 kGy and 2 kGy did, with 1 kGy, therefore, being the minimal dose necessary to achieve sterilization. Microscopic studies showed no relevant changes compared to non-sterilized organs. Axial biomechanical characteristics were not altered at all, and only a slight reduction in the force per unit of length that the organ can radially tolerate was observed. We can therefore conclude that 1 kGy achieves complete sterilization of decellularized rabbit trachea with a minimal, if any, effects on the organ.
- 14 April 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 194,p. e64432
Low-Dose Gamma Radiation Sterilization for Decellularized Tracheal Grafts
One of the main key aspects in ensuring that a transplant evolves correctly is the sterility of the medium. Decellularized tracheal transplantation involves implanting an organ that was originally in contact with the environment, thus not being sterile from the outset. While the decellularization protocol (through detergent exposition [2% sodium dodecyl sulfate], continuous stirring, and osmotic shocks) is conducted in line with aseptic measures, it does not provide sterilization. Therefore, one of the main challenges is ensuring sterility prior to in vivo implantation. Although there are established gamma radiation sterilization protocols for inorganic materials, there are no such measures for organic materials. Additionally, the protocols in place for inorganic materials cannot be applied to organic materials, as the established radiation dose (25 kGy) would completely destroy the implant. This paper studies the effect of an escalated radiation dose in a decellularized rabbit trachea. We maintained the dose range (kGy) and tested escalated doses until finding the minimal dose at which sterilization is achieved. After determining the dose, we studied effects of it on the organ, both histologically and biomechanically. We determined that while 0.5 kGy did not achieve sterility, doses of both 1 kGy and 2 kGy did, with 1 kGy, therefore, being the minimal dose necessary to achieve sterilization. Microscopic studies showed no relevant changes compared to non-sterilized organs. Axial biomechanical characteristics were not altered at all, and only a slight reduction in the force per unit of length that the organ can radially tolerate was observed. We can therefore conclude that 1 kGy achieves complete sterilization of decellularized rabbit trachea with a minimal, if any, effects on the organ.
- Open Access
- 26 August 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (10) , 3677-3680
Lung cancer surgical treatment during the pandemic: a challenging situation
Editorial Lung cancer surgical treatment during the pandemic: a challenging situation Néstor J. Martínez-Hernández, Amparo Roig-Bataller
- 26 August 2022
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (10) , 3677-3680
Open AccessLung cancer surgical treatment during the pandemic: a challenging situation
Editorial Lung cancer surgical treatment during the pandemic: a challenging situation Néstor J. Martínez-Hernández, Amparo Roig-Bataller
- 25 May 2022
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 100 (6) , 320-328
Spanish Society of Thoracic Surgery (SECT) consensus document. Long-term follow-up for operated patients with lung cancer
- 25 May 2022
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 100 (6) , 320-328
Spanish Society of Thoracic Surgery (SECT) consensus document. Long-term follow-up for operated patients with lung cancer
- 6 May 2022
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 58 (5) , T398-T405
[Translated article] Surgical Risk Following Anatomic Lung Resection in Thoracic Surgery: A Prediction Model Derived From a Spanish Multicenter Database
- 6 May 2022
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 58 (5) , T398-T405
[Translated article] Surgical Risk Following Anatomic Lung Resection in Thoracic Surgery: A Prediction Model Derived From a Spanish Multicenter Database